Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases.

Saved in:
Bibliographic Details
Title: Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases.
Authors: Jakubowska M; Malopolska Centre of Biotechnology, Jagiellonian University in Krakow, Krakow, Poland., Costa VM; Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal., Krzeptowski W; Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Drug Addiction Pharmacology, Laboratory of Neuropharmacology and Epigenetics, Krakow, Poland., Dominkuš PP; Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Santos M; REQUIMTE/LAQV, Escola Superior de Saúde, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal; Molecular Oncology & Viral Pathology, IPO-Porto Research Center (CI-IPOP), Portuguese Institute of Oncology, Porto, Portugal., Demirdöğen BC; Department of Biomedical Engineering, TOBB University of Economics and Technology, Ankara, Türkiye., Genç Ş; İzmir Biomedicine and Genome Center, Izmir, Türkiye., Trougakos IP; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece., Kanninen KM; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Winklhofer-Roob BM; Institute for Molecular Biosciences, University of Graz, Graz, Austria., Copple IM; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK., Cuadrado A; Department of Biochemistry, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain; Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de Investigaciones Biomédicas 'Sols-Morreale' UAM-CSIC, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Dolžan V; Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Morgenstern C; Vienna Airway Lab, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria. Electronic address: christina.morgenstern@meduniwien.ac.at.
Source: Redox biology [Redox Biol] 2025 Nov; Vol. 87, pp. 103891. Date of Electronic Publication: 2025 Oct 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first